Abstract
In the 2010 ACCORD blood pressure trial, treating hypertensive diabetic patients intensively to reach a systolic blood pressure (BP) target of <120 mm Hg did not improve outcomes compared with treatment to a standard target of 140 mm Hg (NEJM JW Gen Med Apr 15 2010 and N Engl J Med 2010; 362:1575). Now, in the randomized Systolic Blood Pressure Intervention Trial (SPRINT), researchers compared the same targets in 9361 high-risk nondiabetic hypertensive patients. To enroll in SPRINT, patients were …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
